Compare LOOP & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LOOP | RFL |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Real Estate |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.7M | 63.5M |
| IPO Year | 2010 | 2017 |
| Metric | LOOP | RFL |
|---|---|---|
| Price | $1.50 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 112.3K | 68.9K |
| Earning Date | 01-14-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.27 | ★ 28.28 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,889,000.00 | $917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $174.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7016.99 | 43.96 |
| 52 Week Low | $0.88 | $1.12 |
| 52 Week High | $2.29 | $3.19 |
| Indicator | LOOP | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 65.87 | 41.84 |
| Support Level | $1.44 | $1.15 |
| Resistance Level | $1.75 | $1.59 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 83.87 | 7.41 |
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.